AI-generated summary
The authors studied 44 people with a history of repetitive head acceleration events who received transcranial plus intranasal photobiomodulation every other day for 8 to 10 weeks, with cognitive tests before and after treatment. They report statistically significant group-level improvements in several cognitive domains, with individual-level reliable improvement in 0 to 36 percent of participants depending on the subtest. The authors note that the study is a proof-of-concept and that more robust clinical trials are needed to confirm these findings.
- Participants
- 44
- Who or what was studied
- Adults with a history of repetitive head acceleration events
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The authors state that the study is a proof-of-concept and that more robust designs using clinical trial methodology are needed to confirm the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Intranasal photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.